StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc.

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)

Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%

Thermo Fisher Scientific Adjusted EBITDA by Quarter

Adjusted EBITDA ($M)

QuarterlyAnnual

Thermo Fisher Scientific Adjusted EBITDA: $3,276M in Q3 2026, up 16.5% from a year earlier. That is the highest of the 15 quarters on record here.

Latest, Q3 2026
3,276
Period ended Sep 30, 2026
Change on a year earlier
+16.5%
2,813 in Q3 2025
History
15 quarters
Since Q1 2023
Sources
3
Documents cited below

Where the Q3 2026 figure comes from

“Adjusted EBITDA (non-GAAP measure) $ 2,545 $ 2,631 $ 2,813 $ 3,169 $ 2,705 $ 3,066 $ 3,276”

Source: Q3 2026 Reconciliation of Financial Information ↗

Reported in IR Financial Reconciliation Package (Reconciliation of Adjusted EBITDA).

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAdjusted EBITDA ($M)Year on yearSource
Q3 2026Sep 30, 20263,276+16.5%Q3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20263,066+16.5%Q3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 20262,705+6.3%Q3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20253,169+4.8%Q3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 20252,813+6.0%Q3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 20252,631+0.3%Q3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 20252,545-0.7%Q3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20243,024+7.0%Q4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 20242,653-6.2%Q4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 20242,623-0.6%Q4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 20242,563-0.8%Q4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 20232,826–Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 20232,829–Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 20232,640–Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 20232,583–Q4 & FY2024 Reconciliation of Financial Information ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Adjusted EBITDA ($M), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/adj-ebitda-m

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.